Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Am-pharma B.V.
Headquarters: Utrecht, Netherlands
Website: http://www.am-pharma.com
Year Founded: 2001
Status: Private
BioCentury | Oct 11, 2024
Management Tracks
Flagship takes on a third managing partner
Plus: New CEOs at Wheeler, Abalos, Oncovita, Syneos and Calluna, and updates from Phase, Ziphius and more
BioCentury | Feb 14, 2024
Management Tracks
New CEOs for Enable, StromaCare
Plus: Philippakis joins GV as general partner, and updates from Verily, Meliora, Citryll and Silver Creek
BioCentury | Nov 30, 2023
Management Tracks
Kerr, Zimmermann leaving Generation Bio amid restructuring, headcount cuts
Plus: Sáez becomes Agomab’s chief development officer and updates from Forest Road, PDS, enGene and Pyxis
BioCentury | Nov 17, 2023
Management Tracks
Memo names Erik van den Berg as CEO
Plus: Martin Murphy stepping down as Syncona chair, and updates from Red Tree, OMass and Anagenex
BioCentury | Sep 27, 2023
Management Tracks
Morphic CEO Tipirneni taking medical leave of absence
Plus: David Stack to retire as chair, CEO of Pacira and updates from AM-Pharma, Invitae, Syneos and Faeth
BioCentury | Sep 17, 2021
Management Tracks
Barnett joins Immunovant as CFO
Plus: Celularity, Autolus, Kyverna, AM-Pharma, Saniona and more
BioCentury | Sep 9, 2021
Deals
Sept. 8 Quick Takes: Logos leads crossovers in Attralus’ $116M round
Denner, Bauer join board of pan-amyloid removal company, plus: Resilience-Moderna, Exscientia-Gates
BioCentury | Jul 9, 2021
Management Tracks
Borio joins CEPI as SAB member; plus Aeglea, Codiak, Nordic Nanovector, BioShin and more
Luciana Borio, the senior fellow for global health at the Council on Foreign Relations, became a member of the scientific advisory board at Coalition for Epidemic Preparedness Innovations (CEPI).
BioCentury | Jun 23, 2021
Emerging Company Profile
Abata: engineering targeted Treg cell therapies with TCRs
Emerging Company Profile: Third Rock launches Abata with $95M series A to develop targeted Treg cell therapies for autoimmune disorders
BioCentury | May 5, 2021
Finance
Europe’s top venture fund-raisers in 2018-20: Data Byte
At least six European biotechs raised more than $100 million in 2018-20 and are still private, with Oxford Nanopore Technologies Ltd. topping the list at $314.6 million. A further four companies
Items per page:
1 - 10 of 61